Mitsubishi UFJ Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $55.1M | Buy |
|
|||||
|
2025
Q2 | $36.5M | Buy |
|
|||||
|
2025
Q1 | $28.6M | Buy |
|
|||||
|
2024
Q4 | $22.2M | Buy |
|
|||||
|
2024
Q3 | $23.5M | Buy |
|
|||||
|
2024
Q2 | $19.1M | Buy |
|
|||||
|
2024
Q1 | $10.3M | Buy |
|
|||||
|
2023
Q4 | $10.7M | Buy |
|
|||||
|
2023
Q3 | $9.29M | Buy |
|
|||||
|
2023
Q2 | $8.83M | Buy |
|
|||||
|
2023
Q1 | $8.79M | Buy |
|
|||||
|
2022
Q4 | $9.45M | Buy |
|
|||||
|
2022
Q3 | $7.45M | Buy |
|
|||||
|
2022
Q2 | $5.01M | Buy |
|
|||||
|
2022
Q1 | $5.17M | Buy |
|
|||||
|
2021
Q4 | $5.17M | Buy |
|
|||||
|
2021
Q3 | $5.41M | Sell |
|
|||||
|
2021
Q2 | $4.9M | Buy |
|
|||||
|
2021
Q1 | $3.91M | Buy |
|
|||||
|
2020
Q4 | $3.18M | Buy |
|
|||||
|
2020
Q3 | $3.44M | Buy |
|
|||||
|
2020
Q2 | $2.94M | Buy |
|
|||||
|
2020
Q1 | $1.95M | Sell |
|
|||||
|
2019
Q4 | $2.3M | Buy |
|
|||||
|
2019
Q3 | $1.35M | Buy |
|
|||||
|
2019
Q2 | $1.06M | Buy |
|
|||||
|
2019
Q1 | $1.28M | Buy |
|
|||||
|
2018
Q4 | $898K | Sell |
|
|||||
|
2018
Q3 | $1.17M | Buy |
|
|||||
|
2018
Q2 | $1.09M | Sell |
|
|||||
|
2018
Q1 | $1.4M | Sell |
|
|||||
|
2017
Q4 | $1.67M | Buy |
|
|||||
|
2017
Q3 | $87K | Sell |
|
|||||
|
2017
Q2 | $63K | Sell |
|
|||||
|
2017
Q1 | $43K | Sell |
|
|||||
|
2016
Q4 | $36K | Sell |
|
|||||
|
2016
Q3 | $810K | Buy |
|
|||||
|
2016
Q2 | $653K | Buy |
|
|||||
|
2016
Q1 | $722K | Buy |
|
|||||
|
2015
Q4 | $896K | Buy |
|
|||||
|
2015
Q3 | $710K | Sell |
|
|||||
|
2015
Q2 | $1.08M | Buy |
|